NewsHK
Independent fertility clinics have become an active target for healthcare roll-up capital. Against that backdrop, INVO Fertility, Inc.
(Nasdaq: IVF) disclosed on July 24, 2026 that it had entered into a purchase agreement with Alumni Capital LP.
The deal gives the Sarasota, Florida-based company the right to sell up to $15 million of its common stock to fund the acquisition of established, profitable fertility clinics, with a potential ceiling of $50 million if both parties agree.
The mechanics of the Alumni Capital arrangement The deal takes the form of an "Any Market Purchase Agreement," an on-demand equity line where INVO controls the timing and size of every draw.
Keep reading